Skip to main content
Fig. 1 | SpringerPlus

Fig. 1

From: Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice

Fig. 1

Sample selection flowchart. Note The following international classification of diseases, ninth revision, clinical modification (ICD-9-CM) codes were used to identify female breast cancer: 174.x for primary female breast cancer and codes 196.x-199.x for secondary neoplasm, excluding 196.0, 196.1, 196.3 and 198.2, which may be used to indicate locally advanced breast cancer

Back to article page